-+ 0.00%
-+ 0.00%
-+ 0.00%

INHIBRX BIOSCIENCES ANNOUNCES PRELIMINARY DATA FROM THE PHASE 1 TRIAL OF OZEKIBART (INBRX-109) FOR THE TREATMENT OF COLORECTAL CANCER

Reuters·01/21/2025 22:01:03

Please log in to view news